The Role of CD38 in the Pathogenesis of Cardiorenal Metabolic Disease and Aging, an Approach from Basic Research
Open Access
Abstract
Aging is a major risk factor for the leading causes of mortality, and the incidence of age-related diseases including cardiovascular disease, kidney disease and metabolic disease increases with age. NAD+ is a classic coenzyme that exists in all species, and that plays a crucial role in oxidation–reduction reactions. It is also involved in the regulation of many cellular functions including inflammation, oxidative stress and differentiation. NAD+ declines with aging in various organs, and the reduction in NAD+ is possibly involved in the development of age-related cellular dysfunction in cardiorenal metabolic organs through the accumulation of inflammation and oxidative stress. Levels of NAD+ are regulated by the balance between its synthesis and degradation. CD38 is the main NAD+-degrading enzyme, and CD38 is activated in response to inflammation with aging, which is associated with the reduction in NAD+ levels. In this review, focusing on CD38, we discuss the role of CD38 in aging and the pathogenesis of age-related diseases, including cardiorenal metabolic disease.Keywords
Funding Information
- KAKENHI, Grant-in-Aid for Challenging Exploratory Research (20K21773, 21K08290)
- KAKENHI, Grant-in-Aid for Scientific Research (C) (20K21773, 21K08290)
This publication has 149 references indexed in Scilit:
- Sirtuins and renal diseases: relationship with aging and diabetic nephropathyClinical Science, 2012
- NAD(P)H oxidase-dependent intracellular and extracellular O2•− production in coronary arterial myocytes from CD38 knockout miceFree Radical Biology and Medicine, 2011
- Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in MiceCell Metabolism, 2011
- Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesisNature, 2011
- Pathways and Subcellular Compartmentation of NAD Biosynthesis in Human CellsJournal of Biological Chemistry, 2011
- Cyclic Adenosine Diphosphate Ribose Activates Ryanodine Receptors, whereas NAADP Activates Two-pore Domain ChannelsJournal of Biological Chemistry, 2011
- TPC2 Is a Novel NAADP-sensitive Ca2+ Release Channel, Operating as a Dual Sensor of Luminal pH and Ca2+Journal of Biological Chemistry, 2010
- Purified TPC Isoforms Form NAADP Receptors with Distinct Roles for Ca2+ Signaling and Endolysosomal TraffickingCurrent Biology, 2010
- Mechanism of Cyclizing NAD to Cyclic ADP-ribose by ADP-ribosyl Cyclase and CD38Journal of Biological Chemistry, 2009
- NAADP mobilizes calcium from acidic organelles through two-pore channelsNature, 2009